The MetNET-2 Trial

Clinical trial NCT02823691 · UNKNOWN

Trial details

NCT number: NCT02823691
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2016-04-01
Primary completion: 2021-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.